Bravecto Topical Solution for Dogs, 9.9-22 lbs, (Orange Box), 1 Dose (12-wks. supply)

Bravecto should be administered topically as a single dose every 12 weeks according to the Dosage Schedule below to provide a minimum dose of 11.4 mg/lb (25 mg/kg) body weight.

Bravecto may be administered every 8 weeks in case of potential exposure to Amblyomma americanum ticks.

Bravecto is the only flea and tick treatment to last 12 weeks* with one convenient chew or topical dose. That means nearly 3X longer lasting protection than common monthly treatments. The long-lasting efficacy breaks the flea life cycle and drives fleas into extinction with one dose. And, Bravecto kills ticks faster, killing 100% of attached ticks in 12 hours – whereas other treatments can take over 48 hours.

After you give your pet Bravecto, it quickly reaches tissue fluids just under your dog's or cat's skin. When fleas and ticks feed, they ingest Bravecto and die. Bravecto Chew for Dogs starts killing fleas (Ctenocephalides felis) within 2 hours, and kills ticks (Ixodes ricinus) within 12 hours. Bravecto Chew for Dogs kills fleas, prevents flea infestations, and kills ticks (black-legged tick, American dog tick and brown dog tick) for 12 weeks. Bravecto Chew for Dogs also kills lone star ticks for 8 weeks. Bravecto Topical Solution for Cats kills 100% of fleas within 8 hours. Apply Bravecto Topical Solution for Cats to the base of the skull for full-body protection for 12 weeks. Bravecto Topical Solution for Cats kills fleas, prevents flea infestations, and kills ticks (black-legged tick) for 12 weeks. Bravecto Topical Solution for Cats also kills American dog ticks for 8 weeks.

There are no problems reported in field trials in dogs and cats that received Bravecto alongside other commonly used medicines. However, your veterinarian is your pet's health care expert, so it is always best to discuss all of your pet's treatments with them, whether prescription or over-the-counter supplements.

Yes.

In a well-controlled laboratory study, Bravecto was shown to be safe in Collies known to be MDR-1 gene-deficient. Collies with the defect were administered 3 times the deliverable dose and had no adverse events.

It is always best to discuss your pets' medical treatment with your veterinarian. However, Bravecto has a high margin of safety. In safety studies, Bravecto was tested in healthy dogs and puppies at up to 5X the recommended dose at 8-week intervals for 3 treatments. Therefore, no adverse effects are expected if dogs are inadvertently treated twice with the recommended dose within 12 weeks, but please contact your veterinarian.

Yes. Bravecto Chew for Dogs is vet recommended for puppies and dogs 6 months of age or older who weigh at least 4.4. lbs., and Bravecto Topical for Cats is vet recommended for kittens and cats 6 months of age or older who weigh at least 2.6 lbs.